clonazepam has been researched along with Coronary Heart Disease in 2 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clonazepam and PK 11209 were both inactive in this regard." | 1.28 | Interactions between peripheral-type benzodiazepine receptor ligands and an activator of voltage-operated calcium channels. ( Abraham, S; Bolger, GT; Oz, N; Weissman, BA, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grafing, MR | 1 |
| Lamberti, J | 1 |
| Mostoufi-Moab, E | 1 |
| Beitman, BD | 1 |
| Bolger, GT | 1 |
| Abraham, S | 1 |
| Oz, N | 1 |
| Weissman, BA | 1 |
1 trial available for clonazepam and Coronary Heart Disease
| Article | Year |
|---|---|
Treatment of panic disorder in coronary artery disease.
Topics: Chest Pain; Clonazepam; Coronary Disease; Double-Blind Method; Female; Humans; Middle Aged; Panic Di | 1993 |
1 other study available for clonazepam and Coronary Heart Disease
| Article | Year |
|---|---|
Interactions between peripheral-type benzodiazepine receptor ligands and an activator of voltage-operated calcium channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |